# FDA Inspection 986019 - Greyledge Technologies, LLC - August 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/greyledge-technologies-llc/72d9607c-a200-4a74-981f-3034a5f40710
Source feed: FDA_Inspections

> FDA Inspection 986019 for Greyledge Technologies, LLC on August 17, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 986019
- Company Name: Greyledge Technologies, LLC
- Inspection Date: 2016-08-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1294016 - 2025-12-02](https://www.keypedia.com/records/fda_inspections/greyledge-technologies-llc/39f30fc5-8010-40b0-ac89-b7beb01d42c9)
- [FDA Inspection 1294016 - 2025-12-02](https://www.keypedia.com/records/fda_inspections/greyledge-technologies-llc/b1e1909a-b46a-4f2a-8d9c-be81dc1c6a1b)
- [FDA Inspection 794756 - 2012-08-07](https://www.keypedia.com/records/fda_inspections/greyledge-technologies-llc/95cd3890-6572-4cdf-a402-6a98f4bda32d)

Company: https://www.keypedia.com/companies/greyledge-technologies-llc/d09129d2-3cd3-4ec1-aafd-c35afe8253e3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d